Published in Arch Pathol Lab Med on May 01, 2005
Nodular hidradenoma of the breast: A case report with literature review. Indian J Surg (2009) 1.03
Malignant nodular hidradenoma of the eyelid: a rare sweat gland tumor. Middle East Afr J Ophthalmol (2010) 0.89
Clear cell hidradenoma of breast mimicking atypical breast lesion: a diagnostic pitfall in breast cytology. Rare Tumors (2014) 0.82
Clear cell hidradenoma: An unusual tumor of the oral cavity. J Oral Maxillofac Pathol (2013) 0.82
The aesthetic and oncological challenges in the management of an atypical nodular hidradenoma of the pinna. Indian J Surg Oncol (2014) 0.75
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology (2002) 2.95
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol (2006) 2.60
"Work-Hardenable" ductile bulk metallic glass. Phys Rev Lett (2005) 2.54
Super plastic bulk metallic glasses at room temperature. Science (2007) 2.45
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (2007) 1.96
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol (2005) 1.88
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2008) 1.83
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. J Am Coll Surg (2011) 1.82
Novel anticancer compounds induce apoptosis in melanoma cells. Cell Cycle (2008) 1.76
The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol (2012) 1.66
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res (2006) 1.62
Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol (2006) 1.62
Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol (2004) 1.52
Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc (2005) 1.52
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem (2003) 1.52
Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. Ann Surg Oncol (2006) 1.47
E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Pathol (2004) 1.46
Predicting disease progression after regional therapy for in-transit melanoma. JAMA Surg (2013) 1.44
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg (2009) 1.39
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol (2008) 1.36
Intraoperative radiation therapy. J Clin Oncol (2007) 1.31
Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg (2003) 1.30
Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys (2007) 1.28
Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys (2005) 1.28
Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg (2014) 1.26
Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res (2009) 1.26
NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw (2009) 1.24
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol (2006) 1.21
Correlation of atomic cluster symmetry and glass-forming ability of metallic glass. Phys Rev Lett (2007) 1.21
Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg (2002) 1.15
Spinal cavernous and capillary hemangiomas in adults. Spine (Phila Pa 1976) (2013) 1.14
Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol (2009) 1.11
Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res (2008) 1.11
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.10
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Mol Cancer Ther (2010) 1.08
IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J Immunol (2004) 1.08
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery (2003) 1.08
Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. J Clin Oncol (2011) 1.07
Primary pancreatic lymphoma evaluated by fine-needle aspiration: findings in 14 cases. Am J Clin Pathol (2004) 1.07
Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorder. J Neuropathol Exp Neurol (2009) 1.06
Oncolytic polio virotherapy of cancer. Cancer (2014) 1.05
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood (2007) 1.05
Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods. Cancer (2006) 1.05
Complications following decompression of Chiari malformation Type I in children: dural graft or sealant? J Neurosurg Pediatr (2011) 1.04
Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement. Am J Dermatopathol (2010) 1.04
Metastases in the pancreas from nonhematologic neoplasms: report of 20 cases evaluated by fine-needle aspiration. Diagn Cytopathol (2004) 1.03
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. Ann Surg Oncol (2009) 1.03
Primary intradural extraosseous Ewing sarcoma of the spine: case report and literature review. Neurosurgery (2011) 1.03
The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions. J Surg Oncol (2006) 1.02
Workforce projections for hepato-pancreato-biliary surgery. J Am Coll Surg (2008) 1.02
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment. J Clin Invest (2013) 1.02
Postoperative delirium. Am J Psychiatry (2008) 1.01
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer (2009) 1.01
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity? Ann Surg Oncol (2009) 1.01
Imaging microscopic pigment chemistry in conjunctival melanocytic lesions using pump-probe laser microscopy. Invest Ophthalmol Vis Sci (2013) 1.01
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol (2012) 1.00
Extended resection for pancreatic adenocarcinoma. Oncologist (2007) 0.99
Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol (2006) 0.99
Primary cerebral ALK-1-positive anaplastic large cell lymphoma in a child. Case report and literature review. Pediatr Neurosurg (2007) 0.98
Calcifying pseudoneoplasm of the cerebellopontine angle: case report. Neurosurgery (2011) 0.97
Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc (2011) 0.96
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer. Ann Surg Oncol (2006) 0.95
Capillary hemangioma of the fourth ventricle in an infant. Case report and review of the literature. J Neurosurg (2006) 0.95
Intracranial Ewing sarcoma. Pediatr Blood Cancer (2005) 0.95
Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells. Eur J Immunol (2011) 0.94
The role of local excision in invasive adenocarcinoma of the ampulla of Vater. J Gastrointest Oncol (2013) 0.94
Chemical influence on β-relaxations and the formation of molecule-like metallic glasses. Nat Commun (2013) 0.94
Neoadjuvant therapy for pancreatic cancer: the Duke experience. Surg Oncol Clin N Am (2004) 0.94
Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2010) 0.93
Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Arch Surg (2005) 0.93
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity. Clin Cancer Res (2006) 0.93
Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy. Ann Surg Oncol (2014) 0.93
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity. J Surg Res (2004) 0.92
Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am J Clin Pathol (2004) 0.92
Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA). J Gastrointest Surg (2010) 0.92
The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: evaluation of the inflammatory response. Adv Ther (2008) 0.91
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4. J Immunol (2004) 0.91
Soft tissue sarcoma. J Natl Compr Canc Netw (2007) 0.91
Primary spinal intramedullary adrenal cortical adenoma associated with spinal dysraphism: case report. Neurosurgery (2006) 0.90
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities. Ann Surg Oncol (2011) 0.89
Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses. J Surg Res (2005) 0.89
Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg (2009) 0.89
Regional treatment strategies for in-transit melanoma metastasis. Surg Oncol Clin N Am (2011) 0.89
Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Mol Cancer Ther (2010) 0.89
Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol (2013) 0.89
Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. J Surg Res (2002) 0.89
CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways. J Invest Dermatol (2012) 0.88
Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina (2004) 0.88
Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer (2004) 0.88
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome. J Clin Invest (2013) 0.87
Enhancing melanoma treatment with resveratrol. J Surg Res (2010) 0.87
Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. Am J Surg (2004) 0.87
Primary intramedullary melanocytoma of the spinal cord: case report. Neurosurgery (2009) 0.86
Ectopic brain in the orbit presenting as disc edema in an adult. Orbit (2009) 0.86
Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg (2002) 0.86